home > news > detailed info

Michelle Shogren: The Importance of User Centricity in Times of Change for Clinical Trials

Marcus Evans Evolution Summit

Marcus evans Summits has announced Michelle Shogren, Senior Director of Innovation - Pharma R&D Clinical Operations at Bayer Pharmaceuticals, as a speaker at the upcoming 2020 Evolution Summit this March 2-4 at the Meritage Resort & Spa in Napa, CA.

The 21st Evolution Summit is the premium forum bringing leading drug development executives and solution providers together. As an invitation only event, taking place behind closed doors, the Summit offers an intimate environment for a focused discussion of key new drivers shaping drug development.

The Summit is the perfect opportunity for leading industry executives to widen their peer network while sharpening their knowledge. Developed via a profound dialogue with key market players as well as extensive proprietary research, the event program will showcase over fifteen of the most sought after clinical trial & drug discovery leaders.

Shogren has over 20 years of experience in Clinical Research across many different roles. Beginning her journey as a research nurse and site director, she then took on the role of clinical research associate at a CRO, and finally joined Bayer Pharmaceuticals in 2008 where she has held multiple roles in including Clinical Operations, Training and Quality and her current position in Business Excellence and Innovation.

As the industry looks at new ways of working in clinical trials, it is important to think about who the end users will be and how these changes will affect them. Shogren’s session will address the importance of user centricity in these times of change for clinical trials. Questions on connecting to patients, collection of data and adding new technologies will be asked and new perspectives discussed, with a primary focus on the end users.

For more information on the summit, visit the website or contact
phone +35722849421
email The Meritage Resort & Spa, Napa, CA
Print this page
Send to a friend
News and Press Releases

Creating your Secondary Packaging Strategy

Pharmaceutical and biotechnology companies with a drug product in clinical development are usually focused on a quick commercial launch. Secondary packaging aspects are often less considered. Correlations with secondary packaging (in this context, secondary packaging also includes device assembly and serialization) that are not considered in this phase can have a negative effect on: · further processability · options in the product lifecycle management · cost and time-to-market
More info >>

White Papers

Case Study: Getting the Client’s Trust - Oncology Program

Cmed Clinical Services

Five years ago, a biopharmaceutical company chose Cmed to conduct a phase II oncology study. Cmed’s performance of the study and the good relationship established with the Client led Cmed to be awarded a second oncology trial which a couple of years ago was followed by a third, fourth and fifth.
More info >>

Industry Events

12th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology

8-11 February 2021, Vienna, Austria

In continuation of the very successful scientific meetings in Budapest, Paris, Berlin, Florence, Geneva, Barcelona, Malta, Istanbul, Lisbon, Glasgow and Granada, the 12th PBP World will be held in Vienna from 8-11 Feb 2021. This every two year held conference has gained an ever increasing impact among the pharmaceutical scientists: With up to 1000 submitted abstracts and about 1300 participants it has become a well-established major meeting, attracting scientists from all over the world.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement